This not only confirmed the utility of the Ang1/2 ratio as a functional biomarker of sepsis, but also suggested that Ang1 could be deployed as a prophylactic or therapeutic intervention in neonatal sepsis. The gene discussed is ANGPT1; the disease is Sepsis.